Chronic Obstructive Pulmonary Disease

Aug 30, 2022

Aktis’s Novel Targeted Alpha Radiopharmaceuticals; Koye Partners with Sonde Health; Novartis to Spin Off Sandoz Business; Alcon to Buy Aerie Pharma; Fast Track Designation to Merck’s MK-2060; FDA Approves Ibrutinib for Chronic GvHD; French Authorities Clears BrainVectis’s Clinical Trial; Takeda’s Dengue Vaccine TAK-003 Gets Approval in Indonesia

May 24, 2022

PTC Therapeutics’ Gene Therapy Upstaza; Sanofi and Regeneron’s Dupixent; Bayer CAR-T Collaboration with Atara; FDA Accepts Biohaven’s Zavegepant; AbbVie Files FDA Approval for ABBV-951; Innoviva to Acquire Entasis; FDA Orphan Drug Designation to XMT-2056; FDA Approves Azacitidine for Juvenile Myelomonocytic Leukemia

Apr 08, 2022

Understanding the Chronic Obstructive Pulmonary Disease Increasing Prevalence and Trends

May 26, 2021

Alarming Growth of Chronic Respiratory Diseases (CRDs) and Their Prolonged Impact on the Quality of Life

Jul 15, 2020

What are the Top Five Leading Causes of Deaths in the World?

Mar 09, 2020

Top healthcare innovations changing the healthcare dynamics

Jan 30, 2020

Annovis announces IPO results; Conatus merges with Histogen; Novartis discontinues its generic journey

Nov 20, 2019

World COPD Day

Nov 15, 2019

Is Air Pollution a driver in COPD Treatment Market?

Nov 15, 2018

WORLD CHRONIC OBSTRUCTIVE PULMONARY DISEASE DAY

Newsletter/Whitepaper